Biolase (BIOL) Earning Somewhat Favorable News Coverage, Analysis Shows
News headlines about Biolase (NASDAQ:BIOL) have been trending somewhat positive recently, according to Accern. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies …